BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 17886096)

  • 1. Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp.
    Samaratunga H; Letizia B
    Pathology; 2007 Oct; 39(5):476-81. PubMed ID: 17886096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of Ki-67 expression in the differential diagnosis of prostatic intraepithelial neoplasia and ductal adenocarcinoma.
    Rioux-Leclercq N; Leray E; Patard JJ; Lobel B; Guillé F; Jouan F; Bellaud P; Epstein JI
    Hum Pathol; 2005 May; 36(5):531-5. PubMed ID: 15948120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare histological patterns of prostatic ductal adenocarcinoma.
    Lee TK; Miller JS; Epstein JI
    Pathology; 2010 Jun; 42(4):319-24. PubMed ID: 20438402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study.
    Wang W; Sun X; Epstein JI
    Am J Surg Pathol; 2008 Jun; 32(6):851-7. PubMed ID: 18408595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic ductal adenocarcinoma: a mini review.
    Epstein JI
    Med Princ Pract; 2010; 19(1):82-5. PubMed ID: 19996627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of benign polyp with prostatic-type epithelium in the bulbar urethra].
    Yuhara K; Ishida K; Kanimoto Y
    Hinyokika Kiyo; 2004 Dec; 50(12):873-5. PubMed ID: 15682861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical study of urine cytological preparations from secondary prostatic adenocarcinoma involving the urinary bladder.
    Mai KT; Ahmed I; Robertson SJ; Belanger EC; Veinot JP; Islam S
    Diagn Cytopathol; 2008 Oct; 36(10):715-20. PubMed ID: 18773445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Endometrial' adenocarcinoma of the prostatic urethra arising in a villous polyp. A light microscopic and immunoperoxidase study.
    Walker AN; Mills SE; Fechner RE; Perry JM
    Arch Pathol Lab Med; 1982 Nov; 106(12):624-7. PubMed ID: 6182857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary cytologic findings in patients with benign and malignant adenomatous polyps of the prostatic urethra.
    Schnadig VJ; Adesokan A; Neal D; Gatalica Z
    Arch Pathol Lab Med; 2000 Jul; 124(7):1047-52. PubMed ID: 10888782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.
    Kunju LP; Mehra R; Snyder M; Shah RB
    Am J Clin Pathol; 2006 May; 125(5):675-81. PubMed ID: 16707367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal adenocarcinoma involving the prostate: report of 9 cases.
    Osunkoya AO; Netto GJ; Epstein JI
    Hum Pathol; 2007 Dec; 38(12):1836-41. PubMed ID: 17868775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prostatic adenocarcinoma: a cytopathological study of 50 cases.
    Mai KT; Roustan Delatour NL; Assiri A; Al-Maghrabi H
    Diagn Cytopathol; 2007 Feb; 35(2):91-5. PubMed ID: 17230567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adenomatous polyps with prostatic type epithelium: a report of two cases].
    Komura T; Yoshida T; Morimoto S; Shinka T; Ohkawa T
    Hinyokika Kiyo; 1987 Jul; 33(7):1132-8. PubMed ID: 3318334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesonephric remnants of the prostate: incidence and histologic spectrum.
    Bostwick DG; Qian J; Ma J; Muir TE
    Mod Pathol; 2003 Jul; 16(7):630-5. PubMed ID: 12861057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma.
    Skinnider BF; Oliva E; Young RH; Amin MB
    Am J Surg Pathol; 2004 Jun; 28(6):701-5. PubMed ID: 15166661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.